SIRPA and neoplasm: In recent years, the CD47-SIRPα pathway has been shown to play a crucial role in immune evasion and tumor progression in various cancers, including laryngeal squamous cell carcinoma, non-small cell lung cancer, rectal cancer, and acute myeloid leukemia [10–13].